Responses to alloantigens and transplant rejection Immune
response against grafted cells tissues, or organs CH15 Ch16 Immune
modulators
Slide 2
Chapter 15 Transplantation of tissues and organs The immune
system Third edition Peter Parham (2009)
Slide 3
Identity of transplantation antigens Type and prevention of
immune response in rejection of solid organs Bone marrow
transplantation
Slide 4
Donor
Slide 5
Autograft Isograft Allograft Xenograft MHC Ag Class I Class II
Major histocompatibility complex (MHC) Identity of transplantation
antigens
Slide 6
Hyperacute rejection (within 24h) Acute rejection (first few
weeks) Chronic rejection (months - years) Type and prevention of
immune response in rejection of solid organs
Slide 7
Hyperacute rejection C, blood clotting Pre-existing Ab (e.g.
Anti-MHC, A/B/O) Repeated blood transfusions Repeated pregnancies
Previous graft Immediate graft death
Slide 8
Hyperacute rejection
Slide 9
Cell-mediated immunity (CMI) Acute rejection Th1 response
Macrophages (Type IV hypersensitivity) CTLs Allogeneic T cells The
frequency of T cells specific for any non-self MHC molecules is
relatively high Cross reactivity (first few weeks) MHC
polymorphism
Slide 10
Cross reactivity Self High affinity to non-self MHC Ag Affinity
High frequency of allogeneic T cells
Cancer therapy Genetic diseases of blood cells Chemotherapy
Repopulation Reconstitution of the patients immune system and also
their red cells and platelets Intravenous infusion Bone marrow
transplantation
Slide 17
T cells : thymus MHC restriction Positive selection 17
Slide 18
Hematopoiesis MHC a MHC b MHC axb APC 18
Slide 19
Bone marrow-derived APC Thymic non-lymphoid stroma Bone marrow
chimera Blood type The more HLA allotypes they share, the better it
works
Slide 20
HLA-haploidentical family members
Slide 21
Engraftment: Colonization of HSC in the bone of recipient
Myeloablative therapy Niche Enrichment
Slide 22
Graft-versus-host disease (GVHD) Recipient DC Stringent T-cell
depletion
Slide 23
Tissue inflammation Cytokine storm Activation of allogeneic T
cells Acute GVHD: First few months Graft-versus-leukemia effect
Graft-versus-tumor effect